2019 Pedi Academic - Effects of Maternal Drug Use on Neonates - 10/3/19
2019 Pedi Academic - Effects of Maternal Drug Use on Neonates - 10/3/19
Target Audience
All Interested Pedi Providers
Learning Objectives
At the conclusion of this program, pediatric providers will be better able to:
- Define addiction and describe the epidemiology of substance use disorders among pregnant women
- Describe the effects of the 6 classes of psychoactive substances on the developing fetus
- Describe the effect of intoxication and withdrawal from psychoactive substances in the newborn
- Describe which pharmaceutical treatments of addiction are safe in breastfeeding
Additional Information
Martha Wunsch, MD
Kaiser GSAA Addiction Medicine
All speaker(s) above and planner(s) (Dr. Michael Tsao) have disclosed that they do not have any financial relationships with any commercial interest or any proprietary entity producing health care goods or services that is relevant to this CME program.
Continuing Medical Education
The Kaiser Foundation Hospital GSAA is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Foundation Hospital Hayward/Fremont takes responsibility for the content, quality and scientific integrity of this CME activity.
The Kaiser Foundation Hospital San Leandro/Fremont designates this live activity for a maximum of 1 hour of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™